GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Tecon Biology Co Ltd (SZSE:002100) » Definitions » Change In Receivables

Tecon Biology Co (SZSE:002100) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Tecon Biology Co Change In Receivables?

Tecon Biology Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Tecon Biology Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Tecon Biology Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥855 Mil. It means Tecon Biology Co's Accounts Receivable declined by ¥855 Mil from Dec. 2022 to Dec. 2023 .

Tecon Biology Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥686 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Tecon Biology Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 16.57.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Tecon Biology Co's liquidation value for the three months ended in Mar. 2024 was ¥-3,658 Mil.


Tecon Biology Co Change In Receivables Historical Data

The historical data trend for Tecon Biology Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tecon Biology Co Change In Receivables Chart

Tecon Biology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -484.76 -1,085.40 759.92 -528.52 855.47

Tecon Biology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Tecon Biology Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tecon Biology Co  (SZSE:002100) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Tecon Biology Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=685.629/3776.852*91
=16.57

2. In Ben Graham's calculation of liquidation value, Tecon Biology Co's accounts receivable are only considered to be worth 75% of book value:

Tecon Biology Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2684.266-9227.028+0.75 * 685.629+0.5 * 4740.192
=-3,658

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tecon Biology Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Tecon Biology Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Tecon Biology Co (SZSE:002100) Business Description

Traded in Other Exchanges
N/A
Address
High-tech Zone in Changchun Road, 528 Tiankang Business Building, Xinjiang, Urumqi, CHN, 830011
Tecon Biology Co Ltd is engaged in the production and sales of veterinary biological products and animal disease prevention, modern pig science breeding and breeding, feed research and development and production, and pig slaughtering and processing. The company mainly operates its businesses within domestic markets, with Xinjiang Province as its main market.
Executives
Wang Xiao Supervisors
Pan Yi Ping Executives
Xu Heng Executives
Wu Xiang Yong Director
Sun Wei Hong Independent director
Wu Ming Qi Executives
Wang Xin An Director
Geng Li Xin Directors, executives
Che Xin Hui Supervisors

Tecon Biology Co (SZSE:002100) Headlines

No Headlines